Muscular Atrophy, Spinal
9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Nervous System Diseases, Neurodegenerative Diseases
Narrower: Bulbo-Spinal Atrophy, X-Linked 2, Spinal Muscular Atrophies of Childhood 4
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Apitegromab for spinal muscular atrophies of childhood | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| GC101 for muscular atrophy, spinal | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| OAV101 for bulbo-spinal atrophy, x-linked | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Onasemnogene abeparvovec for bulbo-spinal atrophy, x-linked | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Onasemnogene abeparvovec for muscular atrophy, spinal | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Onasemnogene abeparvovec for spinal muscular atrophies of childhood | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Risdiplam for muscular atrophy, spinal | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
| SKG0201 Injection for spinal muscular atrophies of childhood | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Spinal Cord Stimulator (Octopolar Medtronic Vectris Leads) for spinal muscular atrophies of childhood | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.